ArticleOncoTargets and therapy2018

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis.

Ping Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.